Introduction
T2D, diabetic nephropathy, microalbuminuria, Diabetes
METABOLIC DISEASES, DIABETIC NEPHROPATHY, DIABETES
Diabetes is one of the most common metabolic diseases, and its prevalence is increasing in adults, especially in developing countries such as IranTherefore, considering the limited and contradictory clinical evidence reporting the therapeutic effects of DPP-4 inhibitors, especially linagliptin, on diabetic nephropathy in patients with T2D, this study aimed to investigate the effect of linagliptin on microalbuminuria as a key step in preventing the progression of diabetic nephropathy in patients with T2D.